TugaTech 🖥️

@tugate.ch

2 days ago

Tesla alvo de fogo posto na Austrália com três veículos destruídos

Tesla alvo de fogo posto na Austrália com três veículos destruídos

#alvo #posto #tesla

TugaTech 🖥️

@tugate.ch

2 days ago

Microsoft alvo de nova investigação no Reino Unido sobre o seu software empresarial

Microsoft alvo de nova investigação no Reino Unido sobre o seu software empresarial

#alvo #microsoft #software

StockTitan

@stocktitan.net

3 days ago

Alvotech Publishes 2025 Annual Report Alvotech (NASDAQ: ALVO) published its 2025 Annual Report on March 30, 2026. The report is available in the company's investor relations website and is attached to the announcement in PDF and iXBRL formats. Contact details for media and investors are provided for further inquiries.

#ALVO Alvotech Publishes 2025 Annual Report

www.stocktitan.net/news/ALVO/alvotech-publi...

StockTitan

@stocktitan.net

3 days ago

Alvotech Files Annual Report with the SEC Alvotech (NASDAQ: ALVO) filed its Annual Report 2025 on Form 20-F with the U.S. Securities and Exchange Commission on March 30, 2026. The filing incorporates parts of the Alvotech Annual Report 2025 and is publicly available on the SEC website and Alvotech investor relations site.For investor or media inquiries, Alvotech provided contact emails for media and investor relations on its investor site.

#ALVO Alvotech Files Annual Report with the SEC

www.stocktitan.net/news/ALVO/alvotech-files...

TugaTech 🖥️

@tugate.ch

1 week ago

Conferências científicas: Estudo revela que a maioria das piadas falha o alvo

Conferências científicas: Estudo revela que a maioria das piadas falha o alvo

#alvo #falha

StockTitan

@stocktitan.net

2 weeks ago

Alvotech Q4 2025 and Full Year 2025 Financial Results Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental long ‑ form earnings release providing additional operational details and business update for Q4 2025 and the full year is available at:

#ALVO Alvotech Q4 2025 and Full Year 2025 Financial Results

www.stocktitan.net/news/ALVO/alvotech-q4-20...

TugaTech 🖥️

@tugate.ch

3 weeks ago

OpenAI é alvo de processo da Gracenote por uso não autorizado de metadados

OpenAI é alvo de processo da Gracenote por uso não autorizado de metadados

#alvo #openai #processo

TugaTech 🖥️

@tugate.ch

3 weeks ago

Windows alvo de exploit à venda por 208 mil euros na dark web

Windows alvo de exploit à venda por 208 mil euros na dark web

#alvo #exploit #venda #web #windows

TugaTech 🖥️

@tugate.ch

4 weeks ago

iPhone alvo de ferramenta de espionagem avançada que escapou ao controlo governamental

iPhone alvo de ferramenta de espionagem avançada que escapou ao controlo governamental

#alvo #controlo #espionagem #ferramenta #iphone

TugaTech 🖥️

@tugate.ch

1 month ago

Cisco Catalyst SD-WAN alvo de falha crítica explorada há três anos

Cisco Catalyst SD-WAN alvo de falha crítica explorada há três anos

#alvo #falha #sd #wan

StockTitan

@stocktitan.net

1 month ago

Transactions of Managers and Closely Associated Persons Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons. ATP Holdings ehf. announced a sale of 2,701,617 shares in Alvotech on January 30, 2026, and Aztiq Pharma Partners S.à r.l.

#ALVO Transactions of Managers and Closely Associated Persons

www.stocktitan.net/news/ALVO/transactions-o...

TugaTech 🖥️

@tugate.ch

1 month ago

Segurança Social alvo de novo esquema de mensagens falsas para extorquir contribuintes

Segurança Social alvo de novo esquema de mensagens falsas para extorquir contribuintes

#alvo #esquema #social

TugaTech 🖥️

@tugate.ch

1 month ago

Comissão Europeia alvo de ciberataque: Infraestrutura móvel comprometida e dados expostos

Comissão Europeia alvo de ciberataque: Infraestrutura móvel comprometida e dados expostos

#alvo #dados #europeia

Novo Pinto 🍉🌿🎹🎧

@novopinto.bsky.social

1 month ago

Human Ships Stream Human Ships by Novo Pinto on desktop and mobile. Play over 320 million tracks for free on SoundCloud.

Escucha Human Ships de Novo Pinto | Disfruta de música y audio gratis en SoundCloud
m.soundcloud.com/novo-pinto/h...
m.soundcloud.com/novo-pinto/hum…
#HumanShips by #Future
#boychoir + #Alvo #Marco #Matty
written and produced, created and conduced by #NovoPinto
#moonkey novopinto.music

TugaTech 🖥️

@tugate.ch

1 month ago

Substack alvo de ataque: emails e números de telefone expostos em nova falha

Substack alvo de ataque: emails e números de telefone expostos em nova falha

#alvo #ataque #falha

TugaTech 🖥️

@tugate.ch

2 months ago

Grok continua a gerar nudez sem consentimento e agora o alvo são os homens

Grok continua a gerar nudez sem consentimento e agora o alvo são os homens

#alvo #grok #os #sem

Novo Pinto 🍉🌿🎹🎧

@novopinto.bsky.social

2 months ago

m.soundcloud.com/novo-pinto/vol…
#Volar on #SoundCloud NOW!!!!
#NovoPinto #electronica
#Matty #Marco #Alvo (final voices) novopinto.music

Novo Pinto 🍉🌿🎹🎧

@novopinto.bsky.social

2 months ago

Volar, by Novo Pinto track by Novo Pinto

Volar | Novo Pinto
novopinto.bandcamp.com/track/volar
#Volar is available on #BandCamp NOW!!!!
#electronic #NovoPinto #electronica
#Matty & #Marco & #Alvo (final voices)
novopinto.music

StockTitan

@stocktitan.net

2 months ago

Transactions of Managers and Closely Associated Persons Attached is a copy of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of shares in Alvotech by ATP Holdings ehf. The shares were aquired in two transactions,

#ALVO Transactions of Managers and Closely Associated Persons

www.stocktitan.net/news/ALVO/transactions-o...

StockTitan

@stocktitan.net

2 months ago

#ALVO Transactions of Managers and Closely Associated Persons

www.stocktitan.net/news/ALVO/transactions-o...

StockTitan

@stocktitan.net

3 months ago

Alvotech Secures Term Loan Facility of USD 100 Million Alvotech (NASDAQ: ALVO) secured a USD 100 million senior term loan facility maturing in December 2027 to bolster liquidity and support R&D and global product launches through 2026. The loan carries a 12.50% annual interest rate, payable monthly in cash, and replaces the company's prior working capital ABL, giving access to the full USD 100 million during the two-year term.The financing was led by GoldenTree Asset Management and follows prior refinancing and repricing actions, including a repriced facility at SOFR+6.0% (~9.8%) and a USD 108 million convertible bond placing due 2030.

#ALVO Alvotech Secures Term Loan Facility of USD 100 Million

www.stocktitan.net/news/ALVO/alvotech-secur...

StockTitan

@stocktitan.net

3 months ago

Changes in company's own shares Alvotech (ALVO) filed a notification with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) on 29 Dec 2025 regarding changes in the company's own shares. An attachment titled Alvotech Own Shares Notification 29 Dec 2025 was submitted with the filing. Investors should review the attached notification for the specific details and scope of the share changes.

#ALVO Changes in company's own shares

www.stocktitan.net/news/ALVO/changes-in-com...

TugaTech 🖥️

@tugate.ch

3 months ago

Spotify alvo de recolha massiva de dados: Anna’s Archive diz ter copiado quase toda a biblioteca

Spotify alvo de recolha massiva de dados: Anna’s Archive diz ter copiado quase toda a biblioteca

#alvo #biblioteca #dados #spotify

StockTitan

@stocktitan.net

3 months ago

Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma Alvotech (NASDAQ: ALVO) announced European launches beginning December 22, 2025 for Gobivaz (golimumab, AVT05), its biosimilar to Simponi. Gobivaz is described as the first marketed biosimilar to Simponi worldwide and will be commercialized exclusively in Europe by partner Advanz Pharma. In the UK, adoption is supported by an NHS England tender award, providing a defined procurement framework. Availability across EEA countries will follow national pricing and reimbursement processes. Approval was supported by analytical, pre-clinical and clinical studies; Gobivaz is offered in the same presentations and dosages as the reference product and is manufactured at Alvotech’s facility in Iceland.

#ALVO Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

www.stocktitan.net/news/ALVO/alvotech-annou...

StockTitan

@stocktitan.net

3 months ago

Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering Alvotech (NASDAQ: ALVO) has placed USD 108 million senior unsecured convertible bonds due 22 December 2030 in a significantly oversubscribed private offering.The bonds carry a 6.875% coupon, are issued at par, convert from day 41, and have an initial conversion price of USD 5.9224 (25% premium over USD 4.7379). Net proceeds will fund R&D, scaling production and four global product launches through 2026; the company expects R&D spend of about USD 250 million in 2026.Concurrent activity included a USD ~56 million placement of existing shares to hedge bond investors, a full stock-lending facility, and lock-ups of 3 and 12 months for new shares and equity-linked securities.

#ALVO Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering

www.stocktitan.net/news/ALVO/alvotech-succe...

TugaTech 🖥️

@tugate.ch

4 months ago

Harvard alvo de ciberataque: Esquema de 'vishing' expõe dados de antigos alunos e doadores

Harvard alvo de ciberataque: Esquema de 'vishing' expõe dados de antigos alunos e doadores

#alvo #dados #esquema

StockTitan

@stocktitan.net

4 months ago

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area Alvotech (NASDAQ: ALVO) announced on November 24, 2025 that the European Commission approved AVT03 as a biosimilar to Prolia and Xgeva (denosumab) in the European Economic Area.AVT03 is approved in two presentations: 60 mg/mL pre-filled syringe for osteoporosis (Prolia) and 70 mg/mL vial for prevention of skeletal related events in advanced malignancies (Xgeva). The European denosumab market is stated at approximately US$1.2 billion in the last 12 months through Q2 2025. Commercialisation in Europe will be via partnerships with STADA and Dr. Reddy’s under semi-exclusive rights.

#ALVO Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area

www.stocktitan.net/news/ALVO/alvotech-annou...

StockTitan

@stocktitan.net

4 months ago

ALVO - Alvotech Latest Stock News & Market Updates Alvotech (ALVO) news hub: Track biosimilar developments, financial updates, and regulatory milestones for this global biotech innovator. Stay informed on key partnerships.

#ALVO Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area

www.stocktitan.net/news/ALVO/alvotech-annou...